- Home
- LEGN
as of 09-15-2026 3:46pm EST
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 5.9B | IPO Year: | 2020 |
| Target Price: | $61.33 | AVG Volume (30 days): | 1.6M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $16.24 - $37.50 | Next Earning Date: | 05-12-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 42.68% | Revenue Growth (next year): | 30.52% |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
Stock Insider Trading Activity of Legend Biotech Corporation (LEGN)
Director
Avg Cost/Share
$14.80
Shares
6,000
Total Value
$88,800.00
Owned After
48,604
SEC Form 4
Chief Executive Officer
Avg Cost/Share
$14.78
Shares
5,566
Total Value
$82,265.48
Owned After
241,872
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Casey Patrick John | LEGN | Director | Jun 30, 2026 | Sell | $14.80 | 6,000 | $88,800.00 | 48,604 | |
| Huang Ying | LEGN | Chief Executive Officer | Jun 25, 2026 | Sell | $14.78 | 5,566 | $82,265.48 | 241,872 |
Compare LEGN vs Leading Stocks
See how LEGN stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "LEGN Legend Biotech Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.